Pizzuti Dana 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Aug 21, 2025
Insider Transaction Report
Form 4
Pizzuti Dana
Chief Med and Dev Officer
Transactions
- Sale
Common Stock
2025-08-20$29.18/sh−6,492$189,437→ 66,270 total
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2025.
- [F2]The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sales price of $29.18 per share. The range of sales prices on the transaction date was $28.94 to $29.47 per share. Detailed information on the exact number of shares can be obtained from the Issuer upon request.
- [F3]Includes 529 shares acquired under the Issuer's Employee Stock Purchase Plan.